|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
211 a.a.
|
 |
|
|
|
|
|
|
|
215 a.a.
|
 |
|
|
|
|
|
|
|
30 a.a.
|
 |
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Immune system
|
 |
|
Title:
|
 |
The crystal structure of the cytoplasmic domain of kcsa
|
|
Structure:
|
 |
Fabl. Chain: l. Fabh. Chain: h. Kcsa. Chain: k
|
|
Source:
|
 |
Mus musculus. Organism_taxid: 10090. Escherichia coli. Organism_taxid: 562
|
|
Resolution:
|
 |
|
2.60Å
|
R-factor:
|
0.230
|
R-free:
|
0.276
|
|
|
Authors:
|
 |
S.Uysal,V.Vasquez,V.Tereshko,K.Esaki,F.A.Fellouse,S.S.Sidhu,S.Koide, E.Perozo,A.Kossiakoff
|
Key ref:
|
 |
S.Uysal
et al.
(2009).
Crystal structure of full-length KcsA in its closed conformation.
Proc Natl Acad Sci U S A,
106,
6644-6649.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
08-Sep-08
|
Release date:
|
14-Apr-09
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
No UniProt id for this chain
|
|
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Proc Natl Acad Sci U S A
106:6644-6649
(2009)
|
|
PubMed id:
|
|
|
|
|
| |
|
Crystal structure of full-length KcsA in its closed conformation.
|
|
S.Uysal,
V.Vásquez,
V.Tereshko,
K.Esaki,
F.A.Fellouse,
S.S.Sidhu,
S.Koide,
E.Perozo,
A.Kossiakoff.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
KcsA is a proton-activated, voltage-modulated K(+) channel that has served as
the archetype pore domain in the Kv channel superfamily. Here, we have used
synthetic antigen-binding fragments (Fabs) as crystallographic chaperones to
determine the structure of full-length KcsA at 3.8 A, as well as that of its
isolated C-terminal domain at 2.6 A. The structure of the full-length KcsA-Fab
complex reveals a well-defined, 4-helix bundle that projects approximately 70 A
toward the cytoplasm. This bundle promotes a approximately 15 degree bending in
the inner bundle gate, tightening its diameter and shifting the narrowest point
2 turns of helix below. Functional analysis of the full-length KcsA-Fab complex
suggests that the C-terminal bundle remains whole during gating. We suggest that
this structure likely represents the physiologically relevant closed
conformation of KcsA.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 1.
Crystal structure of FL KcsA in complex with Fab2. (A) CDR
sequences of the 3 Fabs selected against FL KcsA from a
“reduced genetic code” phage display library. Numbering is
according to the Kabat definition (36). Gly is green; Tyr,
yellow, Ser, red; and nondiversified positions, gray. (B)
Crystal packing of the KcsA–Fab2 complex at 3.8 Å. KcsA
is in orange, and the light and heavy chains of the Fab are in
cyan (light chain) and magenta (heavy chain). (C) Simulated
annealing composite-omit 2Fo-Fc map (contoured at 1σ) of FL
KcsA. The red trace shows the fitted model as Cα tracing. (D)
The final model of the KcsA–Fab complex. Three regions
distinguished by the level of symmetry are highlighted: the
fourfold TM segments (blue color; residues 22–117), the
twofold bulge helix (red color; residues 118–135), and the
fourfold distal C-terminal bundle (gray color; residues
136–158). (E and F) Experimental (E) EPR mobility and (F)
NiEdda accessibility parameters (11) from membrane-reconstituted
FL KcsA, mapped on the crystal model of FL KcsA. The scales
represent a linear increase in local dynamics (E) and
accessibility to the aqueous media (F).
|
 |
Figure 2.
Influence of the C-terminal truncation on the conformation of
the inner helix bundle gate. (A) Cα superposition of the
high-resolution truncated KcsA structure (1K4C; red ribbons)
with FL KcsA (blue ribbons). Inset highlights the splaying out
of the inner helix bundle gate between residues 110 and 115,
resulting in a 15° outward tilting. (B) Radius profile
(calculated with the program HOLE; ref. 29) of truncated (red)
and FL KcsA (blue).
|
 |
|
|
| |
Figures were
selected
by the author.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
A.Memic,
V.V.Volgina,
H.A.Gussin,
D.R.Pepperberg,
and
B.K.Kay
(2011).
Generation of recombinant guinea pig antibody fragments to the human GABA(C) receptor.
|
| |
J Immunol Methods,
368,
36-44.
|
 |
|
|
|
|
 |
A.R.Bradbury,
S.Sidhu,
S.Dübel,
and
J.McCafferty
(2011).
Beyond natural antibodies: the power of in vitro display technologies.
|
| |
Nat Biotechnol,
29,
245-254.
|
 |
|
|
|
|
 |
J.C.Pai,
J.A.Culver,
J.E.Drury,
R.S.Motani,
R.L.Lieberman,
and
J.A.Maynard
(2011).
Conversion of scFv peptide-binding specificity for crystal chaperone development.
|
| |
Protein Eng Des Sel,
24,
419-428.
|
 |
|
|
|
|
 |
J.Wang,
J.X.Qiu,
C.Soto,
and
W.F.DeGrado
(2011).
Structural and dynamic mechanisms for the function and inhibition of the M2 proton channel from influenza A virus.
|
| |
Curr Opin Struct Biol,
21,
68-80.
|
 |
|
|
|
|
 |
S.Banerjee,
and
C.M.Nimigean
(2011).
Non-vesicular transfer of membrane proteins from nanoparticles to lipid bilayers.
|
| |
J Gen Physiol,
137,
217-223.
|
 |
|
|
|
|
 |
S.S.Rizk,
M.Paduch,
J.H.Heithaus,
E.M.Duguid,
A.Sandstrom,
and
A.A.Kossiakoff
(2011).
Allosteric control of ligand-binding affinity using engineered conformation-specific effector proteins.
|
| |
Nat Struct Mol Biol,
18,
437-442.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
Y.Koldobskaya,
E.M.Duguid,
D.M.Shechner,
N.B.Suslov,
J.Ye,
S.S.Sidhu,
D.P.Bartel,
S.Koide,
A.A.Kossiakoff,
and
J.A.Piccirilli
(2011).
A portable RNA sequence whose recognition by a synthetic antibody facilitates structural determination.
|
| |
Nat Struct Mol Biol,
18,
100-106.
|
 |
|
|
|
|
 |
A.M.Powl,
A.O.O'Reilly,
A.J.Miles,
and
B.A.Wallace
(2010).
Synchrotron radiation circular dichroism spectroscopy-defined structure of the C-terminal domain of NaChBac and its role in channel assembly.
|
| |
Proc Natl Acad Sci U S A,
107,
14064-14069.
|
 |
|
|
|
|
 |
A.Negoda,
E.Negoda,
and
R.N.Reusch
(2010).
Importance of oligo-R-3-hydroxybutyrates to S. lividans KcsA channel structure and function.
|
| |
Mol Biosyst,
6,
2249-2255.
|
 |
|
|
|
|
 |
D.W.Urry,
K.D.Urry,
W.Szaflarski,
and
M.Nowicki
(2010).
Elastic-contractile model proteins: Physical chemistry, protein function and drug design and delivery.
|
| |
Adv Drug Deliv Rev,
62,
1404-1455.
|
 |
|
|
|
|
 |
E.J.Denning,
and
T.B.Woolf
(2010).
Cooperative nature of gating transitions in K(+) channels as seen from dynamic importance sampling calculations.
|
| |
Proteins,
78,
1105-1119.
|
 |
|
|
|
|
 |
E.Vales,
and
M.Raja
(2010).
The "flipped" state in E71A-K+-channel KcsA exclusively alters the channel gating properties by tetraethylammonium and phosphatidylglycerol.
|
| |
J Membr Biol,
234,
1.
|
 |
|
|
|
|
 |
J.A.Lundbaek,
S.A.Collingwood,
H.I.Ingólfsson,
R.Kapoor,
and
O.S.Andersen
(2010).
Lipid bilayer regulation of membrane protein function: gramicidin channels as molecular force probes.
|
| |
J R Soc Interface,
7,
373-395.
|
 |
|
|
|
|
 |
J.K.Lee,
and
R.M.Stroud
(2010).
Unlocking the eukaryotic membrane protein structural proteome.
|
| |
Curr Opin Struct Biol,
20,
464-470.
|
 |
|
|
|
|
 |
L.G.Cuello,
D.M.Cortes,
V.Jogini,
A.Sompornpisut,
and
E.Perozo
(2010).
A molecular mechanism for proton-dependent gating in KcsA.
|
| |
FEBS Lett,
584,
1126-1132.
|
 |
|
|
|
|
 |
M.F.Sheets,
H.A.Fozzard,
G.M.Lipkind,
and
D.A.Hanck
(2010).
Sodium channel molecular conformations and antiarrhythmic drug affinity.
|
| |
Trends Cardiovasc Med,
20,
16-21.
|
 |
|
|
|
|
 |
M.Hirano,
Y.Takeuchi,
T.Aoki,
T.Yanagida,
and
T.Ide
(2010).
Rearrangements in the KcsA cytoplasmic domain underlie its gating.
|
| |
J Biol Chem,
285,
3777-3783.
|
 |
|
|
|
|
 |
M.Raja
(2010).
The role of extramembranous cytoplasmic termini in assembly and stability of the tetrameric K(+)-channel KcsA.
|
| |
J Membr Biol,
235,
51-61.
|
 |
|
|
|
|
 |
S.Birtalan,
R.D.Fisher,
and
S.S.Sidhu
(2010).
The functional capacity of the natural amino acids for molecular recognition.
|
| |
Mol Biosyst,
6,
1186-1194.
|
 |
|
|
|
|
 |
S.J.Stahl,
N.R.Watts,
C.Rader,
M.A.DiMattia,
R.G.Mage,
I.Palmer,
J.D.Kaufman,
J.M.Grimes,
D.I.Stuart,
A.C.Steven,
and
P.T.Wingfield
(2010).
Generation and characterization of a chimeric rabbit/human Fab for co-crystallization of HIV-1 Rev.
|
| |
J Mol Biol,
397,
697-708.
|
 |
|
|
|
|
 |
Z.S.Derewenda
(2010).
Application of protein engineering to enhance crystallizability and improve crystal properties.
|
| |
Acta Crystallogr D Biol Crystallogr,
66,
604-615.
|
 |
|
|
|
|
 |
Z.Yuchi,
V.P.Pau,
B.X.Lu,
M.Junop,
and
D.S.Yang
(2009).
An engineered right-handed coiled coil domain imparts extreme thermostability to the KcsA channel.
|
| |
FEBS J,
276,
6236-6246.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
');
}
}
 |
|